KNSA
#919
Kiniksa Pharmaceuticals International, plc - Class A Ordinary Shares
78.6 3 USD
+0.01%
Market Price
Secteur: Soins de Santé
Base: USD
Devise de Profit: USD
Range quotidien
Range Annuel
Changement quotidien
+0.70%
Changement Mensuel
+6.41%
Evolution sur 6 mois
+77.74%
Changement Annuel
+98.34%
Clôture Précédente
78.0 8
Open
78.6 3
Low
78.6 3
High
78.6 3
Volume
78
Financials
- Market Capitalization 10 B
- Employee 366
- Founded 2015
- CEO N/A
- Website www.kiniksa.com
- Headquarter N/A
- FIGI N/A
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
65.26
ratio cours/chiffre d'affaires
—
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 892 |  AXSM Axsome Therapeutics, Inc. - Common Stock | 198.52 USD | -0.25% | -4.36% | -7.88% | +52.47% | 10.40 B USD | ||
| 917 |  IONS Ionis Pharmaceuticals, Inc. - Common Stock | 60.36 USD | -1.13% | -2.94% | +14.62% | -16.31% | 10.03 B USD | ||
| 922 |  KYMR Kymera Therapeutics, Inc. - Common Stock | 118.81 USD | +0.56% | -3.12% | +15.61% | +101.03% | 9.88 B USD | ||
| 923 |  CYTK Cytokinetics, Incorporated - Common Stock | 70.91 USD | -1.64% | -9.01% | -7.54% | +22.05% | 9.86 B USD |